{"id": "1376828711450726400", "creation": 1617096519.0, "user_id": "2787579343", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "CyanVac Selects Exothera for the Development and GMP Manufacturing of its COVID-19 Intranasal Vaccine Candidate for Phase III Clinical Trial is #Europe and the #US.\n#vaccine #covid19vaccine #coronavirus #covid19 #COVID #covid19protection #covid19update\n\nhttps://t.co/qajskAnigi https://t.co/WuafxTd2cO", "first_save": 1634559108.199414, "hashtags": ["#EUROPE", "#US", "#VACCINE", "#COVID19VACCINE", "#CORONAVIRUS", "#COVID19", "#COVID", "#COVID19PROTECTION", "#COVID19UPDATE"]}